Results of a 2009 study conducted by researchers at the Mayo Clinic report that the EndoPAT test is “highly predictive” of a major cardiac event, such as a heart attack or stroke, for people who are considered at low or moderate risk based on their Framingham Risk Score. In this Mayo Clinic study, published in the Journal of the American College of Cardiology, Amir Lerman, M.D., a cardiologist at Mayo Clinic and senior author of the study, and other researchers, used an EndoPAT to measure the endothelial health of 270 patients between the ages of 42 and 66 and followed their progress between 1999 and 2007. Review Study Results |